These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12559638)

  • 1. Practical midcourse sample size modification in clinical trials.
    Proschan MA; Liu Q; Hunsberger S
    Control Clin Trials; 2003 Feb; 24(1):4-15. PubMed ID: 12559638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sample size planning approach that considers both statistical significance and clinical significance.
    Jia B; Lynn HS
    Trials; 2015 May; 16():213. PubMed ID: 25962998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unified method for monitoring and analysing controlled trials.
    Grossman J; Parmar MK; Spiegelhalter DJ; Freedman LS
    Stat Med; 1994 Sep; 13(18):1815-26. PubMed ID: 7997715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.
    Friede T; Kieser M
    Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive statistical analysis following sample size modification based on interim review of effect size.
    Hung HM; Cui L; Wang SJ; Lawrence J
    J Biopharm Stat; 2005; 15(4):693-706. PubMed ID: 16022173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size recalculation in internal pilot study designs: a review.
    Friede T; Kieser M
    Biom J; 2006 Aug; 48(4):537-55. PubMed ID: 16972704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian assessment of sample size for clinical trials of cost-effectiveness.
    O'Hagan A; Stevens JW
    Med Decis Making; 2001; 21(3):219-30. PubMed ID: 11386629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive trial designs.
    Lai TL; Lavori PW; Shih MC
    Annu Rev Pharmacol Toxicol; 2012; 52():101-10. PubMed ID: 21838549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple method for calculating power based on a prior trial.
    Borm GF; Bloem BR; Munneke M; Teerenstra S
    J Clin Epidemiol; 2010 Sep; 63(9):992-7. PubMed ID: 20573484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological issues with adaptation of clinical trial design.
    Hung HM; Wang SJ; O'Neill RT
    Pharm Stat; 2006; 5(2):99-107. PubMed ID: 17080766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size reestimation by Bayesian prediction.
    Wang MD
    Biom J; 2007 Jun; 49(3):365-77. PubMed ID: 17623342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What does "power of the study" mean? How to compute the power of a study? How to compute the number of subjects needed for a trial?].
    Mélot C
    Rev Mal Respir; 2003 Sep; 20(4):602-3. PubMed ID: 14528163
    [No Abstract]   [Full Text] [Related]  

  • 18. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (I): unknown correlation between the endpoints.
    Tamhane AC; Wu Y; Mehta CR
    Stat Med; 2012 Aug; 31(19):2027-40. PubMed ID: 22729929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes.
    Stamey JD; Natanegara F; Seaman JW
    J Biopharm Stat; 2013; 23(4):790-803. PubMed ID: 23786161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.